特集:日中のがん治療における伝統薬の役割――最近の進歩
巻頭言 がん治療と伝統薬
一般社団法人 和漢医薬学会 理事長
岐阜医療科学大学薬学部 教授
稲垣直樹
中薬のリンパ腫治療への応用とその進展
中国中医科学院西苑医院血液科
劉為易 胡暁梅※1
※1 主任医師
福建中医薬大学附属第三人民医院
王賀 邱晨曦 鄭榕 付海英※2
※2 副主任医師
The Application and Progress of Traditional Chinese Medicine in The Treatment of Lymphoma
【Abstract】
Lymphoma is a hematological malignancy with high incidence, easy recurrence, and poor prognosis; furthermore, its treatment is difficult. It has come to be well understood in recent years in Traditional Chinese Medicine(TCM). In patients with lymphoma, TCM can not only restore and enhance the body’s immune function but also improve the patients’ quality of life, prevent recurrence, and prolong survival. This paper discusses the application and progress of TCM in the management of lymphoma based on the Expert Consensus on the Diagnosis and Treatment of Lymphoma with Integrated Traditional Chinese and Western Medicine(2020 edition), in order to provide a reference for the clinical application of TCM in lymphoma treatment.
【Key words】
Traditional Chinese Medicine, Lymphoma, Malignant nodule, Clinical application, Research progress
中医学によるがんの予防・治療に関する研究の進展
中山大学腫瘍予防治療センター総合中医科
範騰 黄圓圓 張蓓※1
※1 主任
Advances in Traditional Chinese Medicine Research for the Prevention and Treatment of Cancer
【Abstract】
The incidence of cancer has been increasing in recent years. Traditional Chinese Medicine(TCM)can play an important role in the prevention and treatment of cancer. Numerous clinical studies have shown that TCM has unique advantages in enhancing the efficacy and reducing the toxicity of radiotherapy, chemotherapy, and targeted drugs, and preventing tumor metastasis and recurrence. At the same time, basic mechanistic research of TCM on cancer has progressed. Importantly, TCM not only shows unique advantages in inducing autophagy, promoting cancer cell apoptosis, and reversing drug resistance, but also has a regulatory effect on the immune micro-environment in patients. However, clinical and basic research on TCM for the prevention and treatment of cancer still has some shortcomings. These include the characteristics of TCM treatment and the complexity of TCM components, as well as insufficient knowledge about key target diseases for TCM and its mechanism. Here, we summarize current advances in TCM research with regard to the prevention and treatment of cancer.
【Key words】
Traditional Chinese medicine, Cancer, Curative Effect Enhancement, Side Effects Reduction
日本のがん治療における伝統薬の役割 ― 漢方薬基礎研究の最前線
東京慈恵会医科大学疼痛制御研究講座 特任教授
国立がん研究センター東病院支持・緩和研究開発支援室 特任研究員
上園保仁
東京慈恵会医科大学疼痛制御研究講座 特任准教授
宮野加奈子
The Roles of Traditional Herbal Medicine in Cancer Therapy ― The Front Line of Basic Research on Japanese Kampo Medicine
【Abstract】
Traditional herbal medicines have been used to recently used to maintain and improve the quality of life of cancer patients in Japan. The scientific significance of Japanese Kampo medicine has increased in recent years because of advances in related basic research, and the findings have translated to clinical practice. In this special issue, we review the latest information on the front line of basic research on Japanese Kampo medicine, which originally developed in China as Chinese traditional herbal medicine.
【Key words】
Targets for herbal medicine, Daikenchuto, Hangeshashinto, Synergistic action, Rikkunshito
がんサポーティブケアにおける漢方の意義とエビデンス
金沢医科大学 名誉教授
元雄良治
Significance of and Evidence for the Use of Kampo Medicine in Supportive Care for Cancer
【Abstract】
Kampo, the traditional Japanese Medicine originating from ancient Chinese Medicine, has been applied for the management of refractory side effects of chemotherapy, such as anorexia, general malaise, and peripheral neuropathy. For example, there are randomized controlled trials on rikkunnshito for anorexia, hochuekkito for cancer-related fatigue, goshajinkigan for peripheral neuropathy, and hangeshashinto for oral mucositis and diarrhea. Kampo is expected to be recognized and demanded by modern medicine doctors as well as patients receiving modern medicinal treatment.
【Key words】
Kampo, Supportive care, Cancer, Chemotherapy, Adverse event
|
弔辞 中国関係機関からのお悔やみ状 |
---|---|
架け橋 |
日中ナノメディシン交流 |
笹川生 in China |
心の中の灯台――恩師玄学南教授 |
あとがき | 広報委員会委員 袁 博 |
機関誌『日中医学』投稿原稿募集の お知らせ |